Akums Gets CDSCO Nod for Colchicine The Story:Sanofi Healthcare India has acquired a 15.19% stake in Sanofi India for ₹1,068.2 crore, with the shares transferred internally from fellow promoter entity...
Key Highlights: Implications: Sun Pharma has signed an exclusive global licensing deal (ex‑US and ex‑China) with LIB Therapeutics for lerodalcibep, a once‑monthly PCSK9 inhibitor for lower...
Summary The Top 10 R&D Spending Indian Biopharma Companies of 2026 reflect the country’s growing commitment to pharmaceutical innovation, advanced drug develop...
Key Highlights: Implications: Sun Pharma’s acquisition of Innovcare looks like a portfolio-building move in India: for about ₹271.2 crore, Sun is buying a growing busin...
Summary The Top 10 Generic Pharmaceutical Companies of 2025 highlight the continued growth and resilience of the global generics industry, led by Sandoz, Sun Pharma, and Fosun Pharma....
Key Highlights: Implications: Sun Pharma is making its biggest strategic pivot yet with the planned all‑cash takeover of Organon, using the deal to jump from an India‑anchor...
Key Highlights: Implications: By launching semaglutide under two differentiated brands with full dose coverage and price points 60%+ below innovator levels, Sun is set to rapidly expand ac...
